nemvaleukin alfa – Patient Worthy

source: pixabay.com

Nemvaleukin Alfa + Pembrolizumab Earn Fast Track Designation for Ovarian Cancer

Post author:Jessica Lynn
Post published:November 3, 2021
Post category:Ovarian Cancer

Sometimes, treatments used in conjunction with each other can confer benefits for patients. According to the Cancer Network, for example, treating platinum-resistant ovarian cancer using nemvaleukin alfa and pembrolizumab (Keytruda)…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More